Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Bacterial DNA and DNA synthesis enzyme systems represent a critical suite of molecular targets for antimicrobial therapy, encompassing enzymes essential for the replication, repair, and topological maintenance of the bacterial genome. Central to this system are DNA gyrase (Topoisomerase II) and Topoisomerase IV, which regulate DNA supercoiling and the separation of interlinked daughter chromosomes during cell division (Bush et al., 2020). Additionally, the system includes DNA polymerases responsible for strand elongation and the metabolic pathways, such as the folate cycle, that provide the necessary nucleotide precursors (Scholar, 2014). Inhibition of these processes typically results in the cessation of bacterial growth (bacteriostatic) or direct chromosomal fragmentation and cell death (bactericidal). Drugs targeting these systems, such as fluoroquinolones and metronidazole, are widely used to treat a broad spectrum of infections, though their efficacy is increasingly challenged by the emergence of resistant bacterial strains (Aldred et al., 2014). Because these bacterial enzymes often differ significantly in structure from their eukaryotic counterparts, they serve as highly effective targets for selective toxicity in treating various bacterial infections (Robinson & van Oijen, 2013).
Drugs targeting this system act through several distinct mechanisms: fluoroquinolones bind to DNA gyrase and topoisomerase IV, trapping the enzyme-DNA cleavage complex and causing lethal double-strand breaks (Bush et al., 2020); metronidazole undergoes reductive activation in anaerobic bacteria to form reactive intermediates that directly damage DNA (NCBI, PubChem); and folate antagonists like trimethoprim and sulfonamides inhibit the synthesis of tetrahydrofolate, thereby depleting the thymidine and purine pools required for DNA assembly (Scholar, 2014).
7 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Bacterial DNA and DNA synthesis enzyme systems.